keyword
MENU ▼
Read by QxMD icon Read
search

Crvo review

keyword
https://www.readbyqxmd.com/read/27902540/macular-perivenous-retinal-whitening-and-presumed-retino-ciliary-sparing-in-a-recurrent-central-retinal-vein-occlusion-associated-with-the-antiphospholipid-syndrome-and-cryoglobulinemia
#1
Dov B Sebrow, Jesse J Jung, Jason Horowitz, Jeffrey G Odel, K Bailey Freund
PURPOSE: Macular perivenous retinal whitening results from hypoperfusion-induced ischemia of the middle retina that can occur in central retinal vein occlusion (CRVO). We describe an unusual case of recurrent CRVO with macular perivenous retinal whitening and retino-ciliary venous sparing in the setting of 2 prothrombotic diseases, antiphospholipid syndrome and Type II cryoglobulinemia. METHODS: A 50-year-old man presented with intermittent loss of vision in his right eye related to a recurrent CRVO...
November 29, 2016: Retinal Cases & Brief Reports
https://www.readbyqxmd.com/read/27742504/skull-base-osseous-arteriovenous-fistula-a-rare-clinical-entity-case-report-and-literature-review
#2
Aneesh Mohimen, Santhosh Kumar Kannath, E R Jayadevan
PURPOSE: To describe a rare clinical entity of intraosseous skull base arteriovenous fistula managed with transvenous fistula embolization. CASE PRESENTATION: A 57-year-old woman presented with complaints of headache and episodic tinnitus with progressive left-sided visual deterioration. Cross-sectional imaging of the head revealed multiple vascular channels in the sphenoid bone and in bilateral masticator spaces. Catheter angiography showed the presence of a large osseous arteriovenous fistula epicentered in the body of sphenoid and left pterygoid plates with arterial feeders from bilateral external carotid arteries and venous drainage into bilateral cavernous sinuses and the pterygoid venous plexus...
October 11, 2016: World Neurosurgery
https://www.readbyqxmd.com/read/27585711/retinal-oximetry-in-patients-with-ischaemic-retinal-diseases
#3
Sandra Rilvén, Thomas Lee Torp, Jakob Grauslund
The retinal oximeter is a new tool for non-invasive measurement of retinal oxygen saturation in humans. Several studies have investigated the associations between retinal oxygen saturation and retinal diseases. In the present systematic review, we examine whether there are associations between retinal oxygen saturation and retinal ischaemic diseases. We used PubMed and Embase to search for retinal oxygen saturation and retinal ischaemic diseases. Three separate searches identified a total of 79 publications...
September 1, 2016: Acta Ophthalmologica
https://www.readbyqxmd.com/read/27319943/an-unusual-case-of-central-retinal-vein-occlusion-and-review-of-the-toxicity-profile-of-regorafenib-in-gist-patients
#4
REVIEW
Gustavo Schvartsman, Michael J Wagner, Chrystia M Zobniw, Van Anh Trinh, Shreyaskumar Patel, Neeta Somaiah
Gastrointestinal stromal tumor (GIST) is the most common sarcoma of the gastrointestinal tract with around 5000 new cases per year. Outcomes for patients with GIST dramatically improved after the development of tyrosine kinase inhibitors targeted against the aberrant signaling pathways that drive GIST oncogenesis. Majority of patients derive benefit from first-line imatinib, and the type of driver mutation is predictive of response. However, almost half of the patients eventually develop resistance to initial targeted therapy and further lines of treatment do not have the same impact...
August 2016: Current Oncology Reports
https://www.readbyqxmd.com/read/27274409/perioperative-visual-loss-following-prone-spinal-surgery-a-review
#5
Nancy E Epstein
BACKGROUND: Postoperative visual loss (POVL) following prone spine surgery occurs in from 0.013% to 1% of cases and is variously attributed to ischemic optic neuropathy (ION: anterior ION or posterior ION [reported in 1.9/10,000 cases: constitutes 89% of all POVL cases], central retinal artery occlusion [CRAO], central retinal vein occlusion [CRVO], cortical blindness [CB], direct compression [horseshoe, prone pillows, and eye protectors Dupaco Opti-Gard]), and acute angle closure glaucoma (AACG)...
2016: Surgical Neurology International
https://www.readbyqxmd.com/read/27158615/comparison-of-anti-vascular-endothelial-growth-factors-laser-treatments-and-a-combination-of-the-both-for-treatment-of-central-retinal-vein-occlusion
#6
Yoav Y Pikkel, Adi Sharabi-Nov, Itzchak Beiran, Joseph Pikkel
AIM: To compare changes in visual acuity and macular edema in patients with central retinal vein occlusion (CRVO) treated with intravitreal injections of bevacizumab, macular grid photocoagulation combined with pan retinal photocoagulation (PRP), or both (bevacizumab+grid+PRP). METHODS: Our study is a retrospective cohort clinical study that examined patients that suffered from ischemic CRVO with macular edema. Study inclusion criteria were ischemic CRVO with macula edema and the availability of complete medical records for at least 12mo after treatment...
2016: International Journal of Ophthalmology
https://www.readbyqxmd.com/read/27034199/optical-coherence-tomography-angiography-in-paracentral-acute-middle-maculopathy-secondary-to-central-retinal-vein-occlusion
#7
G Casalino, M Williams, C McAvoy, F Bandello, U Chakravarthy
PurposeTo report the clinical course and the optical coherence tomography angiography (OCTA) findings of patients presenting with paracentral acute middle maculopathy (PAMM) and central retinal vein occlusion (CRVO).MethodsRetrospective case series. Clincal records and multimodal imaging findings of patients presenting with PAMM and CRVO were reviewed.ResultsThree eyes of three patients (2 males; mean age: 66 years) were included in the study. Mean follow-up was 9 months and images using OCTA (AngioVue OCT angiography system, Optovue, Inc...
June 2016: Eye
https://www.readbyqxmd.com/read/26957838/central-retinal-vein-occlusion-a-review-of-current-evidence-based-treatment-options
#8
REVIEW
Amy Patel, Christine Nguyen, Stephanie Lu
A central retinal vein occlusion (CRVO) can induce an ischemic and hypoxic state with resulting sequelae of macular edema and neovascularization. Many treatment options have been studied. Our review aims to investigate the safety and efficacy of the multiple treatment options of CRVO. A PubMed and Cochrane literature search was performed. Well-controlled randomized clinical trials that demonstrated strong level 1 evidence-based on the rating scale developed by the British Centre for Evidence-Based Medicine were included...
January 2016: Middle East African Journal of Ophthalmology
https://www.readbyqxmd.com/read/26869163/central-retinal-vein-occlusion-modifying-current-treatment-protocols
#9
REVIEW
M Ashraf, A A R Souka, R P Singh
Central retinal vein occlusion (CRVO) is a common retinal vascular disorder that can result in severe visual acuity loss. The randomized control study, CRUISE, helped establish anti-VEGFs as the standard of care in cases with CRVO. The extension studies for CRUISE; HORIZON and RETAIN showed that not all visual gains are maintained beyond the first year. In addition, patients showed different behavior patterns; with some patients showing complete response with few recurrences, whereas others showed partial or even no response with multiple recurrences...
April 2016: Eye
https://www.readbyqxmd.com/read/26854482/-morphologic-patterns-on-spectral-domain-optical-coherence-tomography-sd-oct-as-a-prognostic-indicator-in-treatment-of-macular-edema-due-to-retinal-vein-occlusion
#10
T Groneberg, J S Trattnig, N Feucht, C P Lohmann, M Maier
BACKGROUND: SD-OCT is an important tool in the diagnosis of macular oedema (ME) due to retinal vein occlusion (RVO). Its high resolution makes it possible to distinguish various morphological characteristics and differences. The aim of this study is to evaluate the correlation between morphological patterns and the development of visual acuity (VA) after intravitreal treatment of ME due to RVO. METHODS: 81 patients on intravitreal treatment (dexamethasone: n = 53/ranibizumab: n = 28) due to ME associated with branch and central retinal vein occlusion ( BRVO: n = 38/CRVO: n = 43) were retrospectively reviewed...
September 2016: Klinische Monatsblätter Für Augenheilkunde
https://www.readbyqxmd.com/read/26635973/steroids-in-central-retinal-vein-occlusion-is-there-a-role-in-current-treatment-practice
#11
REVIEW
Mohammed Ashraf, Ahmed A R Souka
With the current widespread use of anti-VEGFs in the treatment of central retinal vein occlusion (CRVO), the role for steroids has become greatly diminished. Recent large scale randomized control trials (RCTs) have established the efficacy and safety of anti-VEGFs in the treatment of CRVO. Steroids are known to cause elevations in intraocular pressure as well as increase the risk of cataract formation. With that in mind many ophthalmologists are injecting steroids less frequently. This paper aims to review some of the data pertaining to the use of steroids either as a first line monotherapy, adjunct therapy, or an alternative therapy to help answer the question: Is there currently any role for steroids in the management of CRVO?...
2015: Journal of Ophthalmology
https://www.readbyqxmd.com/read/26449196/intravitreal-aflibercept-for-macular-oedema-secondary-to-central-retinal-vein-occlusion-in-patients-with-prior-treatment-with-bevacizumab-or-ranibizumab
#12
MULTICENTER STUDY
T D Papakostas, L Lim, T van Zyl, J B Miller, B S Modjtahedi, C M Andreoli, D Wu, L H Young, I K Kim, D G Vavvas, D D Esmaili, D Husain, D Eliott, L A Kim
PurposeTo report the visual and anatomic outcomes in eyes with macular oedema (MO) secondary to central retinal vein occlusion (CRVO) that were switched from either intravitreal bevacizumab or ranibizumab to intravitreal aflibercept.MethodsTwo-center retrospective chart review. Eyes with MO secondary to CRVO that received a minimum of three intravitreal injections of bevacizumab or ranibizumab and were switched to intravitreal aflibercept for persistent or recurrent MO not responding to either bevacizumab and/or ranibizumab...
January 2016: Eye
https://www.readbyqxmd.com/read/26352007/intravitreal-steroids-versus-observation-for-macular-edema-secondary-to-central-retinal-vein-occlusion
#13
REVIEW
Dina Gewaily, Karthikeyan Muthuswamy, Paul B Greenberg
BACKGROUND: Central retinal vein occlusion (CRVO) is a common retinal vascular abnormality associated with conditions such as hypertension, diabetes, glaucoma, and a wide variety of hematologic disorders. Macular edema (ME) represents an important vision-threatening complication of CRVO. Intravitreal steroids (IVS), such as triamcinolone acetonide, have been utilized to treat macular edema stemming from a variety of etiologies and may be a treatment option for CRVO-ME. OBJECTIVES: To explore the effectiveness and safety of intravitreal steroids in the treatment of CRVO-ME...
September 9, 2015: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/26337664/two-or-more-dexamethasone-intravitreal-implants-in-treatment-na%C3%A3-ve-patients-with-macular-edema-due-to-retinal-vein-occlusion-subgroup-analysis-of-a-retrospective-chart-review-study
#14
MULTICENTER STUDY
Pravin U Dugel, Antonio Capone, Michael A Singer, Richard F Dreyer, David G Dodwell, Daniel B Roth, Rui Shi, John G Walt, Lanita C Scott, David A Hollander
BACKGROUND: Dexamethasone intravitreal implant (DEX implant) is a biodegradable, sustained-release implant that releases dexamethasone for up to 6 months. We evaluated the efficacy and safety of DEX implant in the treatment of macular edema secondary to retinal vein occlusion (RVO) in treatment-naïve patients. METHODS: A multicenter, retrospective, open-label chart review study investigated the efficacy and safety of DEX implant treatment in 289 patients with macular edema secondary to branch or central RVO (BRVO, CRVO) who received ≥2 treatments with DEX implant in the study eye...
2015: BMC Ophthalmology
https://www.readbyqxmd.com/read/26214803/significant-correlation-between-retinal-venous-tortuosity-and-aqueous-vascular-endothelial-growth-factor-concentration-in-eyes-with-central-retinal-vein-occlusion
#15
Shunsuke Yasuda, Shu Kachi, Mineo Kondo, Shinji Ueno, Hiroki Kaneko, Hiroko Terasaki
PURPOSE: To determine whether the degree of venous tortuosity is significantly correlated with the aqueous vascular endothelial growth factor (VEGF) concentration in eyes with a central retinal vein occlusion (CRVO). METHODS: We reviewed the medical records of 32 eyes of 32 patients who had macular edema due to a CRVO. All of the patients were examined at the Nagoya University Hospital and were scheduled to receive an intravitreal injection of bevacizumab (IVB) or ranibizumab (IVR) within 12 weeks of the onset of the CRVO to treat the macular edema...
2015: PloS One
https://www.readbyqxmd.com/read/26088287/optimal-treatment-of-retinal-vein-occlusion-canadian-expert-consensus
#16
REVIEW
Alan R Berger, Alan F Cruess, Filiberto Altomare, Varun Chaudhary, Kevin Colleaux, Mark Greve, Amin Kherani, Efrem D Mandelcorn, Hugh Parsons, Marc-André Rhéaume, Eric Tourville
BACKGROUND: The availability of new therapeutic approaches, particularly intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapies, has prompted significant changes to the established treatment paradigms for retinal vein occlusion (RVO). Better visual outcomes and significantly lower rates of adverse events have been noted in multiple large randomized clinical trials and have led to a new standard of care for this sight-threatening condition. OBJECTIVE: To develop an expert consensus for the management of RVO and associated complications in the context of recent clinical evidence...
2015: Ophthalmologica. Journal International D'ophtalmologie
https://www.readbyqxmd.com/read/26073857/anti-vegf-therapy-for-retinal-vein-occlusions
#17
Claudio Campa, Giuseppe Alivernini, Elena Bolletta, Maurizio Battaglia Parodi, Paolo Perri
Retinal vein occlusion (RVO) is the second most common cause of visual loss in the Western World. RVO is usually classified into branch RVO (BRVO) and central RVO (CRVO) according to the anatomical site of the vascular occlusion. The pathogenesis of RVO is not yet fully understood, however an important event is the intraluminal thrombus formation, which is usually secondary to several conditions such as hypertension, hyperlipidemia, diabetes and thrombophilia. The blockage of venous circulation causes an elevation of intraluminal pressure in the capillaries, leading to hemorrhages and leakage of fluid within the retina, increase of interstitial pressure and a consequent reduction of retinal perfusion...
2016: Current Drug Targets
https://www.readbyqxmd.com/read/26067779/efficacy-and-safety-of-dexamethasone-intravitreal-implant-for-treatment-of-refractory-macular-edema-secondary-to-retinal-vein-occlusion-in-taiwan
#18
Shwu-Jiuan Sheu, Tsung-Tien Wu, Yu-Harn Horng
PURPOSE: To evaluate the long-term efficacy and safety of slow-release dexamethasone intravitreal implant (DEX implant) in patients with refractory macular edema (ME) secondary to retinal vein occlusion (RVO) in Taiwan. METHODS: We conducted a retrospective chart review of patients with a diagnosis of ME secondary to RVO who received the DEX implant at Kaohsiung Veterans General Hospital from October 2010 to February 2014. RESULTS: A total of 28 patients with an average age of 60...
October 2015: Journal of Ocular Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/25925049/-management-of-aflibercept-in-routine-clinical-practice
#19
F Cabrera López
Aflibercept is a new anti-vegf drug that, unlike ranibizumab and bevacizumab blocks both vegf-A and placental growth factor. Moreover, it binds with much greater strength and affinity to human VEGF-A165 than other endogenous vegf receptors, conferring it with a more extended effect and allowing a lower frequency of intravitreal injections. This facilitates the adoption of fixed treatment regimens other than monthly or individual regimens such as "treat and extend". Aflibercept is indicated for the treatment of neovascular (exudative) age-related macular degeneration (ARMD), visual alteration due to macular edema secondary to central retinal vein occlusion (CRVO) and visual alteration due to diabetic macular edema (DME)...
March 2015: Archivos de la Sociedad Española de Oftalmología
https://www.readbyqxmd.com/read/25709772/neovascular-events-in-eyes-with-central-retinal-vein-occlusion-undergoing-serial-bevacizumab-or-ranibizumab-intravitreal-injections-a-retrospective-review
#20
Francis Char DeCroos, Bozho Todorich, Rayan Alshareef, Mohammed Khuthaila, Sharon Fekrat, Allen C Ho, Carl D Regillo, Marc J Spirn
PURPOSE: To characterize the onset and type of neovascular events in eyes with central retinal vein occlusion (CRVO) undergoing serial anti-VEGF therapy. METHODS: Consecutive eyes undergoing serial intravitreal bevacizumab or ranibizumab injections for treatment of CME secondary to CRVO were identified. Pertinent data was retrospectively collected and included type and onset of the neovascular event, and the treatment free interval from last injection until the neovascular event...
October 2014: Journal of Ophthalmic & Vision Research
keyword
keyword
6412
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"